B3GNTL1P2

Across TCGA pan-cancer cohorts, B3GNTL1P2 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated B3GNTL1P2 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher B3GNTL1P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated B3GNTL1P2 expression acts as an unfavorable survival marker.

KIRC, STAD, and READ are the cancer types where B3GNTL1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.525	0.648	.011	61	view →
STAD	DFS	Tertile	All	0.471	0.730	.006	45	view →
READ	DFS	Tertile	All	0.269	0.819	.009	45	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
UCS	DFS	Tertile	All	0.136	0.523	.034	18	view →
KIRP	DFS	Tertile	All	0.456	0.641	.012	18	view →
SARC	DFS	Tertile	All	0.113	0.595	.001	18	view →
COAD	DFS	Tertile	II,III,IV	0.141	0.683	.022	9	view →
LIHC	DFS	Tertile	All	0.148	0.533	.010	9	view →
LGG	OS	Tertile	All	0.598	0.889	.008	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

B3GNTL1P2–KIRC (OS)

Open the KIRC breakdown →